Yamakawa T, Kagechika H, Kawachi E, Hashimoto Y, Shudo K
Faculty of Pharmaceutical Sciences, University of Tokyo, Japan.
J Med Chem. 1990 May;33(5):1430-7. doi: 10.1021/jm00167a024.
The retinoidal activities of trimethylsilyl or trimethylgermyl-containing retinobenzoic acids are discussed on the basis of differentiation-inducing activity on human promyelocytic leukemia cells HL-60. Compounds with a trimethylsilyl or trimethylgermyl group at the meta position of the generic formula 2 have more potent activities than the corresponding retinobenzoic acids with a m-tert-butyl group. Compounds having two m-trimethylsilyl or -trimethylgermyl groups also have strong activities, and (E)-4-[3-[3,5-bis(trimethylsilyl)phenyl]-3-oxo-1-propenyl]benzoic acid (22, Ch55S) and (E)-4-[3-[3,5-bis(trimethylgermyl)phenyl]-3-oxo-1- propenyl]benzoic acid (35, Ch55G) are more active than retinoic acid by 1 order of magnitude. However, in the para-substituted chalcone derivatives, the replacement of a tert-butyl group (49, Ch40) with a trimethylsilyl (27, Ch40S) or a trimethylgermyl (30, Ch40G) group caused the disappearance of the activity.
基于对人早幼粒细胞白血病细胞HL-60的分化诱导活性,讨论了含三甲基硅基或三甲基锗基的视黄酸苯甲酸的视黄酸活性。通式2中,在间位带有三甲基硅基或三甲基锗基的化合物比相应的带有间叔丁基的视黄酸苯甲酸具有更强的活性。具有两个间位三甲基硅基或三甲基锗基的化合物也具有较强的活性,并且(E)-4-[3-[3,5-双(三甲基硅基)苯基]-3-氧代-1-丙烯基]苯甲酸(22,Ch55S)和(E)-4-[3-[3,5-双(三甲基锗基)苯基]-3-氧代-1-丙烯基]苯甲酸(35,Ch55G)比维甲酸的活性高一个数量级。然而,在对位取代的查耳酮衍生物中,用三甲基硅基(27,Ch40S)或三甲基锗基(30,Ch40G)取代叔丁基(49,Ch40)会导致活性消失。